iifl-logo

PGIM India Healthcare Fund Direct IDCW

PGIM India Healthcare Fund Direct IDCW

Fund Name

PGIM India Mutual Fund

Scheme Name

PGIM India Healthcare Fund Direct IDCW

AMC

PGIM India Mutual Fund

Type

:  Open

Category

Equity - Pharma

Launch Date

19-Nov-2024

Fund Manager

Anandha Padmanabhan Anjen

Net Assets (Rs. cr)

107.51

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

PGIM India Healthcare Fund Direct IDCW - Nav Details

Nav Date

:  05-Jun-2025

NAV [Rs.]

:  9.74

Buy/Resale Price [Rs.]

0

Sell/Repurchase Price [Rs.]

0

Entry Load %

Nil

Exit Load %

For Exits within 90 days from date of allotment of units: 0.50% For Exits beyond 90 days from date of allotment of units: NIL

PGIM India Healthcare Fund Direct IDCW- NAV Chart

PGIM India Healthcare Fund Direct IDCW- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
1.03
1.24
9.19
-
-
-
-
-2.6
Category Avg
0.64
1.74
8.92
-3.8
19.89
24.84
22.23
17.69
Category Best
1.32
5.25
15.13
-0.14
30.95
29.5
26.01
36.02
Category Worst
-0.06
-0.33
4.57
-8.85
11.81
20.12
16.87
-4.96

PGIM India Healthcare Fund Direct IDCW- Latest Dividends

No Records Found

PGIM India Healthcare Fund Direct IDCW- Investment Details

Min. Investment(Rs.)

5000

Increm.Investment(Rs.)

1000

In & Out

In

InName Of The CompanyNo Of Shares
--

Out

InName Of The CompanyNo Of Shares
--

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquitySun Pharma.Inds.Pharmaceuticals & Biotechnology13.067664814.04
EquityDivi's Lab.Pharmaceuticals & Biotechnology7.75136968.33
EquityMax HealthcareHealthcare Services6.94679217.45
EquityDr Reddy's LabsPharmaceuticals & Biotechnology6.04548916.49
EquityMankind PharmaPharmaceuticals & Biotechnology4.83210755.19
EquityAster DM Health.Healthcare Services4.781018495.14
EquityTorrent Pharma.Pharmaceuticals & Biotechnology3.90126104.18
EquityKrishna Institu.Healthcare Services3.58585773.84
EquityAjanta PharmaPharmaceuticals & Biotechnology3.33132403.58
EquityAbbott IndiaPharmaceuticals & Biotechnology3.3111883.56
EquityJ B Chemicals &Pharmaceuticals & Biotechnology3.15210143.38
EquityGlobal HealthHealthcare Services2.95264713.16
EquityICICI LombardInsurance2.86163883.07
EquityCiplaPharmaceuticals & Biotechnology2.84197003.05
EquityPB Fintech.Financial Technology (Fintech)2.61172622.80
EquityDr Lal PathlabsHealthcare Services2.4394452.61
EquityJupiter Life LinHealthcare Services2.27166302.44
EquityNavin Fluo.Intl.Chemicals & Petrochemicals2.1851912.34
EquityIpca Labs.Pharmaceuticals & Biotechnology2.10160842.25
EquitySyngene Intl.Healthcare Services2.06350052.21
EquityRainbow Child.Healthcare Services1.93150352.07
EquitySagility IndiaIT - Services1.914999082.05
EquityNeuland Labs.Pharmaceuticals & Biotechnology1.8916942.03
EquitySanofi ConsumerPharmaceuticals & Biotechnology1.8139361.94
EquitySanofi IndiaPharmaceuticals & Biotechnology1.6028971.72
EquityZydus Lifesci.Pharmaceuticals & Biotechnology0.97117661.04
EquitySai LifePharmaceuticals & Biotechnology0.93145741.01
EquityOrchid PharmaPharmaceuticals & Biotechnology0.7296410.77
EquityAkums DrugsPharmaceuticals & Biotechnology0.2960410.31
Cash & Cash Equivalent
Reverse RepoC C I-/-4.5404.88
Net CA & OthersNet CA & Others-/-0.4300.42

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
PGIM India Mutual Fund
Incorporation Date:
24-Sep-2008
Total Assets Managed (Cr.):
24,164.95
Trustee/s:
Rakesh Sood, PGIM India Trustees Priva, Mr. Vijay Agarwal, Mr. Sujal Shah, Mr. John Praveen, Mr. Ashwini Kakkar
Chairman:
NA
CEO / MD:
Ajit Menon, Mr. Ajit Menon
CIO:
NA
President:
NA
Director/s:
Mr.Muralidharan Rajamani, Glenwyn Peter Baptist, Kapil Wadhawan, Mr.David Wan Chang, Mr.Indrasena Yala Reddy, Dr. V. R. Narasimham
Compliance Officer/s:
Mr. Sandeep Kamath, Mr. Sumesh Kumar
Investor Service Officer/s:
Murali Ramasubramanian
Fund Manager/s:
Anandha Padmanabhan Anjen
Auditors:
Price Waterhouse Chartere

OTHER INFORMATION

Registered Office:
4th Floor, C Wing, Laxmi Towers, Bandra Kurla Complex, Bandra (East), Mumbai - 400 051
Contact Nos:
022-61593000
Fax:
022-61593100
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.